midodrine has been researched along with Bradykinesia in 1 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Torigoe, K | 1 |
| Numata, O | 1 |
| Ogawa, Y | 1 |
| Kaneko, U | 1 |
| Usuda, T | 1 |
| Imamura, M | 1 |
| Takeuchi, K | 1 |
| Suzuki, H | 1 |
| Endo, H | 1 |
1 other study available for midodrine and Bradykinesia
| Article | Year |
|---|---|
Contingent negative variation in children with orthostatic dysregulation.
Topics: Adolescent; Blood Pressure; Child; Contingent Negative Variation; Female; Humans; Hypokinesia; Hypot | 2001 |